Life science company Epitopea, rooted in Cambridge UK and both Montreal and Quebec in Canada, has clinched a licensing deal ...

Cambridge-based anti-ageing biotech Shift Bioscience has set up a team and facilities in Canada to serve North America. The ...

Cambridge GaN Devices, a trailblazer in gallium nitride (GaN) power electronics technology, has closed a $32 million Series C ...

Experienced finance chief William J. Kullback has joined the board of Cambridge biotech business Nuclera as a Non Executive ...

Luminance, a Cambridge-based pioneer in Legal-Grade™ AI, has raised $75 million in a Series C funding round, taking the total ...

Pharma specialist Bicycle Therapeutics is headquartered in Cambridge UK but quoted on Nasdaq in the US. It employs around 300 ...

BMZ Group, a leading European manufacturer of cross-industry lithium-ion battery systems, is offering the opportunity of a ...

Blueshift Memory, a Cambridge-based designer of a novel proprietary high-speed memory architecture, has secured a £1.2 ...

The next biotech breakthrough won’t happen in isolation, which is why regional hubs are so critical to life science success, ...

A multibillion dollar open commerce business founded by entrepreneurs in Cambridge and New York is slated to float on Nasdaq.

Cambridge-based FLIT, an engineering company that builds folding electric bikes for urban commuters, has raised £1.2 million ...

Broken String Biosciences, a leader in advancing gene editing safety, has opened its Catalyst Early Access Program (EAP) for ...